Drug Shortage Report for TEVA-TOPISONE
Report ID | 17832 |
Drug Identification Number | 00809187 |
Brand name | RATIO-TOPISONE |
Common or Proper name | TOPISONE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BETAMETHASONE |
Strength(s) | 0.05% |
Dosage form(s) | LOTION |
Route of administration | TOPICAL |
Packaging size | 75ML |
ATC code | D07AC |
ATC description | CORTICOSTEROIDS, PLAIN |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2017-07-30 |
Estimated end date | 2017-09-30 |
Actual end date | 2017-10-16 |
Shortage status | Resolved |
Updated date | 2017-10-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-10-17 | English | Compare |
v4 | 2017-10-10 | French | Compare |
v3 | 2017-10-10 | English | Compare |
v2 | 2017-08-01 | French | Compare |
v1 | 2017-08-01 | English | Compare |
Showing 1 to 5 of 5